Neurizon Therapeutics has reported positive topline results from an open-label extension (OLE) study of its lead candidate ...

The ALS therapy ATH-1105 entered the brain and spinal cord at dose-proportional levels in healthy volunteers, and had a good ...

Mitsubishi Tanabe Pharma America’s (MTPA) oral therapy Radicava (edaravone) has shown decreased functional decline and ...

ROME, AUG 19 - An Italo-US team of scientists have made a breakthrough in the early diagnosis of amyotrophic lateral sclerosis (ALS), also known as Motor Neuron Disease or Lou Gehrig's Disease, ...

By analyzing millions of messenger RNA molecules (mRNA) during the course of ALS, researchers at Stockholm University, in ...

Jodi O’Donnell-Ames founded Hope Loves Company to provide support, resources, and community to children affected by ALS.

Amyotrophic Lateral Sclerosis Treatment Market Distribution Channel Insights Hospital pharmacies held a significant revenue share in the amyotrophic lateral sclerosis (ALS) treatment market in ...

Amyotrophic lateral sclerosis (ALS) is a progressive, disabling, and fatal neurodegenerative disorder that causes muscle weakness, disability, and eventually death. 1 It is most common in adults ...

More information: C Sahara Khademullah et al, Cortical interneuron-mediated inhibition delays the onset of amyotrophic lateral sclerosis, Brain (2020). DOI: 10.1093/brain/awaa034 ...

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease predominantly affecting upper and lower motor neurons. Here, the authors outline previous and current efforts to characterize ...

Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease for which a precise cause has not yet been identified. Standard CT or MRI evaluation does not demonstrate gross structural ...

BOYNTON BEACH, Fla. — Boynton Beach Mayor Ty Penserga proclaimed Sept. 28 as ALS Awareness Day. Amyotrophic lateral sclerosis is a disease that attacks the nervous system, affecting nerve cells ...